<?xml version='1.0' encoding='UTF-8'?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Neuropsychopharmacology</journal-id>
      <journal-id journal-id-type="iso-abbrev">Neuropsychopharmacology</journal-id>
      <journal-title-group>
        <journal-title>Neuropsychopharmacology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0893-133X</issn>
      <issn pub-type="epub">1740-634X</issn>
      <publisher>
        <publisher-name>Springer International Publishing</publisher-name>
        <publisher-loc>Cham</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">35982238</article-id>
      <article-id pub-id-type="pmc">9556592</article-id>
      <article-id pub-id-type="publisher-id">1385</article-id>
      <article-id pub-id-type="doi">10.1038/s41386-022-01385-3</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The impact of visual dysfunctions in recent-onset psychosis and clinical high-risk state for psychosis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Schwarzer</surname>
            <given-names>Johanna M.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Meyhoefer</surname>
            <given-names>Inga</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Antonucci</surname>
            <given-names>Linda A.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kambeitz-Ilankovic</surname>
            <given-names>Lana</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Surmann</surname>
            <given-names>Marian</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bienek</surname>
            <given-names>Olga</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Romer</surname>
            <given-names>Georg</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dannlowski</surname>
            <given-names>Udo</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hahn</surname>
            <given-names>Tim</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Korda</surname>
            <given-names>Alexandra</given-names>
          </name>
          <xref ref-type="aff" rid="Aff7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3949-5867</contrib-id>
          <name>
            <surname>Dwyer</surname>
            <given-names>Dominic B.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ruef</surname>
            <given-names>Anne</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1385-1050</contrib-id>
          <name>
            <surname>Haas</surname>
            <given-names>Shalaila S.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rosen</surname>
            <given-names>Marlene</given-names>
          </name>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lichtenstein</surname>
            <given-names>Theresa</given-names>
          </name>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ruhrmann</surname>
            <given-names>Stephan</given-names>
          </name>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8988-3959</contrib-id>
          <name>
            <surname>Kambeitz</surname>
            <given-names>Joseph</given-names>
          </name>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8532-1596</contrib-id>
          <name>
            <surname>Salokangas</surname>
            <given-names>Raimo K. R.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9565-0238</contrib-id>
          <name>
            <surname>Pantelis</surname>
            <given-names>Christos</given-names>
          </name>
          <xref ref-type="aff" rid="Aff10">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1956-9574</contrib-id>
          <name>
            <surname>Schultze-Lutter</surname>
            <given-names>Frauke</given-names>
          </name>
          <xref ref-type="aff" rid="Aff11">11</xref>
          <xref ref-type="aff" rid="Aff12">12</xref>
          <xref ref-type="aff" rid="Aff13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Meisenzahl</surname>
            <given-names>Eva</given-names>
          </name>
          <xref ref-type="aff" rid="Aff11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4021-8456</contrib-id>
          <name>
            <surname>Brambilla</surname>
            <given-names>Paolo</given-names>
          </name>
          <xref ref-type="aff" rid="Aff14">14</xref>
          <xref ref-type="aff" rid="Aff15">15</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bertolino</surname>
            <given-names>Alessandro</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Borgwardt</surname>
            <given-names>Stefan</given-names>
          </name>
          <xref ref-type="aff" rid="Aff7">7</xref>
          <xref ref-type="aff" rid="Aff16">16</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Upthegrove</surname>
            <given-names>Rachel</given-names>
          </name>
          <xref ref-type="aff" rid="Aff17">17</xref>
          <xref ref-type="aff" rid="Aff18">18</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6825-6262</contrib-id>
          <name>
            <surname>Koutsouleris</surname>
            <given-names>Nikolaos</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
          <xref ref-type="aff" rid="Aff19">19</xref>
          <xref ref-type="aff" rid="Aff20">20</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4032-7297</contrib-id>
          <name>
            <surname>Lencer</surname>
            <given-names>Rebekka</given-names>
          </name>
          <address>
            <email>rebekka.lencer@uni-muenster.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff7">7</xref>
        </contrib>
        <contrib contrib-type="author" id="IAu1">
          <collab>the PRONIA Consortium<contrib-group><contrib contrib-type="author"><name><surname>Hasan</surname><given-names>Alkomiet</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Hoff</surname><given-names>Claudius</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Khanyaree</surname><given-names>Ifrah</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Melo</surname><given-names>Aylin</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Muckenhuber-Sternbauer</surname><given-names>Susanna</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Köhler</surname><given-names>Yanis</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Öztürk</surname><given-names>Ömer</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Penzel</surname><given-names>Nora</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Popovic</surname><given-names>David</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Rangnick</surname><given-names>Adrian</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>von Saldern</surname><given-names>Sebastian</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Sanfelici</surname><given-names>Rachele</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Spangemacher</surname><given-names>Moritz</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Tupac</surname><given-names>Ana</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Urquijo</surname><given-names>Maria Fernanda</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Weiske</surname><given-names>Johanna</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Wosgien</surname><given-names>Antonia</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Krämer</surname><given-names>Camilla</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Blume</surname><given-names>Karsten</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Julkowski</surname><given-names>Dominika</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Kaden</surname><given-names>Nathalie</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Milz</surname><given-names>Ruth</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Nikolaides</surname><given-names>Alexandra</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Vent</surname><given-names>Mauro Silke</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Wassen</surname><given-names>Martina</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Andreou</surname><given-names>Christina</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name><surname>Egloff</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name><surname>Harrisberger</surname><given-names>Fabienne</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name><surname>Heitz</surname><given-names>Ulrike</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name><surname>Lenz</surname><given-names>Claudia</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name><surname>Leanza</surname><given-names>Letizia</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name><surname>Mackintosh</surname><given-names>Amatya</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name><surname>Smieskova</surname><given-names>Renata</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name><surname>Studerus</surname><given-names>Erich</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name><surname>Walter</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name><surname>Widmayer</surname><given-names>Sonja</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><name><surname>Day</surname><given-names>Chris</given-names></name><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name><surname>Griffiths</surname><given-names>Sian Lowri</given-names></name><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name><surname>Iqbal</surname><given-names>Mariam</given-names></name><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name><surname>Pelton</surname><given-names>Mirabel</given-names></name><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name><surname>Mallikarjun</surname><given-names>Pavan</given-names></name><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name><surname>Stainton</surname><given-names>Alexandra</given-names></name><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name><surname>Lin</surname><given-names>Ashleigh</given-names></name><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name><surname>Lalousis</surname><given-names>Paris</given-names></name><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><name><surname>Denissoff</surname><given-names>Alexander</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Ellilä</surname><given-names>Anu</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>From</surname><given-names>Tiina</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Heinimaa</surname><given-names>Markus</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Ilonen</surname><given-names>Tuula</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Jalo</surname><given-names>Päivi</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Laurikainen</surname><given-names>Heikki</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Luutonen</surname><given-names>Antti</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Mäkela</surname><given-names>Akseli</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Paju</surname><given-names>Janina</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Pesonen</surname><given-names>Henri</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Säilä</surname><given-names>Reetta-Liina</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Toivonen</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Turtonen</surname><given-names>Otto</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Botterweck</surname><given-names>Sonja</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Kluthausen</surname><given-names>Norman</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Antoch</surname><given-names>Gerald</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Caspers</surname><given-names>Julian</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Wittsack</surname><given-names>Hans-Jörg</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Solana</surname><given-names>Ana Beatriz</given-names></name><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name><surname>Abraham</surname><given-names>Manuela</given-names></name><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name><surname>Schirmer</surname><given-names>Timo</given-names></name><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name><surname>Altamura</surname><given-names>Carlo</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name><surname>Belleri</surname><given-names>Marika</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name><surname>Bottinelli</surname><given-names>Francesca</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name><surname>Ferro</surname><given-names>Adele</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name><surname>Re</surname><given-names>Marta</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name><surname>Monzani</surname><given-names>Emiliano</given-names></name><xref ref-type="aff" rid="Aff22">22</xref></contrib><contrib contrib-type="author"><name><surname>Sberna</surname><given-names>Maurizio</given-names></name><xref ref-type="aff" rid="Aff22">22</xref></contrib><contrib contrib-type="author"><name><surname>D’Agostino</surname><given-names>Armando</given-names></name><xref ref-type="aff" rid="Aff23">23</xref></contrib><contrib contrib-type="author"><name><surname>Del Fabro</surname><given-names>Lorenzo</given-names></name><xref ref-type="aff" rid="Aff23">23</xref></contrib><contrib contrib-type="author"><name><surname>Perna</surname><given-names>Giampaolo</given-names></name><xref ref-type="aff" rid="Aff24">24</xref></contrib><contrib contrib-type="author"><name><surname>Nobile</surname><given-names>Maria</given-names></name><xref ref-type="aff" rid="Aff24">24</xref></contrib><contrib contrib-type="author"><name><surname>Alciati</surname><given-names>Alessandra</given-names></name><xref ref-type="aff" rid="Aff24">24</xref></contrib><contrib contrib-type="author"><name><surname>Balestrieri</surname><given-names>Matteo</given-names></name><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><name><surname>Bonivento</surname><given-names>Carolina</given-names></name><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><name><surname>Cabras</surname><given-names>Giuseppe</given-names></name><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><name><surname>Fabbro</surname><given-names>Franco</given-names></name><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><name><surname>Garzitto</surname><given-names>Marco</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib><contrib contrib-type="author"><name><surname>Piccin</surname><given-names>Sara</given-names></name><xref ref-type="aff" rid="Aff26">26</xref></contrib></contrib-group></collab>
        </contrib>
        <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.5949.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2172 9288</institution-id><institution>Institute for Translational Psychiatry, </institution><institution>University of Muenster, </institution></institution-wrap>Muenster, Germany </aff>
        <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.7644.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 0120 3326</institution-id><institution>Department of Basic Medical Science, Neuroscience and Sense Organs, </institution><institution>University of Bari Aldo Moro, </institution></institution-wrap>Bari, Italy </aff>
        <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.7644.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 0120 3326</institution-id><institution>Department of Education, Psychology, Communication, </institution><institution>University of Bari Aldo Moro, </institution></institution-wrap>Bari, Italy </aff>
        <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.5252.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 973X</institution-id><institution>Department of Psychiatry and Psychotherapy, </institution><institution>Ludwig Maximilian University Munich, </institution></institution-wrap>Munich, Germany </aff>
        <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.6190.e</institution-id><institution-id institution-id-type="ISNI">0000 0000 8580 3777</institution-id><institution>Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, </institution><institution>University of Cologne, </institution></institution-wrap>Cologne, Germany </aff>
        <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.5949.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2172 9288</institution-id><institution>Department of Child Adolescence Psychiatry and Psychotherapy, </institution><institution>University of Muenster, </institution></institution-wrap>Muenster, Germany </aff>
        <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.4562.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 0057 2672</institution-id><institution>Department of Psychiatry and Psychotherapy, </institution><institution>University of Luebeck, </institution></institution-wrap>Luebeck, Germany </aff>
        <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Department of Psychiatry, </institution><institution>Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.1374.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2097 1371</institution-id><institution>Department of Psychiatry, </institution><institution>University of Turku, </institution></institution-wrap>Turku, Finland </aff>
        <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.1008.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 088X</institution-id><institution>Melbourne Neuropsychiatry Centre, </institution><institution>University of Melbourne and Melbourne Health, </institution></institution-wrap>Melbourne, VIC Australia </aff>
        <aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="GRID">grid.411327.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2176 9917</institution-id><institution>Department of Psychiatry and Psychotherapy, Medical Faculty, </institution><institution>Heinrich-Heine University, </institution></institution-wrap>Duesseldorf, Germany </aff>
        <aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="GRID">grid.5734.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 0726 5157</institution-id><institution>University Hospital of Child and Adolescent Psychiatry and Psychotherapy, </institution><institution>University of Bern, </institution></institution-wrap>Bern, Switzerland </aff>
        <aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="GRID">grid.440745.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0152 762X</institution-id><institution>Department of Psychology, Faculty of Psychology, </institution><institution>Airlangga University, </institution></institution-wrap>Surabaya, Indonesia </aff>
        <aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="GRID">grid.414818.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 8749</institution-id><institution>Department of Neurosciences and Mental Health, </institution><institution>Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, </institution></institution-wrap>Milan, Italy </aff>
        <aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="GRID">grid.4708.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 2822</institution-id><institution>Department of Pathophysiology and Transplantation, </institution><institution>University of Milan, </institution></institution-wrap>Milan, Italy </aff>
        <aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="GRID">grid.6612.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0642</institution-id><institution>Department of Psychiatry, Psychiatric University Hospital, </institution><institution>University of Basel, </institution></institution-wrap>Basel, Switzerland </aff>
        <aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="GRID">grid.6572.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7486</institution-id><institution>Institute for Mental Health, and Centre for Human Brain Health, School of Psychology, </institution><institution>University of Birmingham, </institution></institution-wrap>Birmingham, UK </aff>
        <aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="GRID">grid.498025.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0376 6175</institution-id><institution>Birmingham Early Intervention Service, </institution><institution>Birmingham Womens and Childrens NHS Foundation Trust, </institution></institution-wrap>Birmingham, UK </aff>
        <aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="GRID">grid.13097.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2322 6764</institution-id><institution>Institute of Psychiatry, Psychology and Neuroscience, </institution><institution>King’s College London, </institution></institution-wrap>London, UK </aff>
        <aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="GRID">grid.419548.5</institution-id><institution-id institution-id-type="ISNI">0000 0000 9497 5095</institution-id><institution>Max-Planck-Institute of Psychiatry, </institution></institution-wrap>Munich, Germany </aff>
        <aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="GRID">grid.418143.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 0943 0267</institution-id><institution>General Electric Global Research Inc, </institution></institution-wrap>Niskayuna, NY USA </aff>
        <aff id="Aff22"><label>22</label><institution-wrap><institution-id institution-id-type="GRID">grid.416200.1</institution-id><institution>Programma 2000, Niguarda Hospital, </institution></institution-wrap>Milan, Italy </aff>
        <aff id="Aff23"><label>23</label><institution-wrap><institution-id institution-id-type="GRID">grid.415093.a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1793 3800</institution-id><institution>San Paolo Hospital, </institution></institution-wrap>Milan, Italy </aff>
        <aff id="Aff24"><label>24</label>Villa San Benedetto Menni, Albese con Cassano, CO Italy </aff>
        <aff id="Aff25"><label>25</label><institution-wrap><institution-id institution-id-type="GRID">grid.5390.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 2113 062X</institution-id><institution>Department of Medical Area, </institution><institution>University of Udine, </institution></institution-wrap>Udine, Italy </aff>
        <aff id="Aff26"><label>26</label>IRCCS Scientific Institute “E. Medea”, Polo FVG, Udine, Italy </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>18</day>
        <month>8</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>18</day>
        <month>8</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>11</month>
        <year>2022</year>
      </pub-date>
      <volume>47</volume>
      <issue>12</issue>
      <fpage>2051</fpage>
      <lpage>2060</lpage>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>3</month>
          <year>2022</year>
        </date>
        <date date-type="rev-recd">
          <day>2</day>
          <month>7</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>7</day>
          <month>7</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© The Author(s) 2022</copyright-statement>
        <license>
          <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p id="Par1">Subtle subjective visual dysfunctions (VisDys) are reported by about 50% of patients with schizophrenia and are suggested to predict psychosis states. Deeper insight into VisDys, particularly in early psychosis states, could foster the understanding of basic disease mechanisms mediating susceptibility to psychosis, and thereby inform preventive interventions. We systematically investigated the relationship between VisDys and core clinical measures across three early phase psychiatric conditions. Second, we used a novel multivariate pattern analysis approach to predict VisDys by resting-state functional connectivity within relevant brain systems. VisDys assessed with the Schizophrenia Proneness Instrument (SPI-A), clinical measures, and resting-state fMRI data were examined in recent-onset psychosis (ROP, <italic>n</italic> = 147), clinical high-risk states of psychosis (CHR, <italic>n</italic> = 143), recent-onset depression (ROD, <italic>n</italic> = 151), and healthy controls (HC, <italic>n</italic> = 280). Our multivariate pattern analysis approach used pairwise functional connectivity within occipital (ON) and frontoparietal (FPN) networks implicated in visual information processing to predict VisDys. VisDys were reported more often in ROP (50.34%), and CHR (55.94%) than in ROD (16.56%), and HC (4.28%). Higher severity of VisDys was associated with less functional remission in both CHR and ROP, and, in CHR specifically, lower quality of life (Qol), higher depressiveness, and more severe impairment of visuospatial constructability. ON functional connectivity predicted presence of VisDys in ROP (balanced accuracy 60.17%, <italic>p</italic> = 0.0001) and CHR (67.38%, <italic>p</italic> = 0.029), while in the combined ROP + CHR sample VisDys were predicted by FPN (61.11%, <italic>p</italic> = 0.006). These large-sample study findings suggest that VisDys are clinically highly relevant not only in ROP but especially in CHR, being closely related to aspects of functional outcome, depressiveness, and Qol. Findings from multivariate pattern analysis support a model of functional integrity within ON and FPN driving the VisDys phenomenon and being implicated in core disease mechanisms of early psychosis states.</p>
      </abstract>
      <kwd-group kwd-group-type="npg-subject">
        <title>Subject terms</title>
        <kwd>Predictive markers</kwd>
        <kwd>Psychosis</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100011272</institution-id>
              <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>602152</award-id>
          <award-id>602152</award-id>
          <award-id>602152</award-id>
          <award-id>602152</award-id>
          <award-id>602152</award-id>
          <award-id>602152</award-id>
          <award-id>602152</award-id>
          <award-id>602152</award-id>
          <award-id>602152</award-id>
          <award-id>602152</award-id>
          <award-id>602152</award-id>
          <award-id>602152</award-id>
          <award-id>601152</award-id>
          <award-id>602152</award-id>
          <award-id>602152</award-id>
          <award-id>602152</award-id>
          <award-id>602152</award-id>
          <award-id>602152</award-id>
          <award-id>602152</award-id>
          <award-id>602152</award-id>
          <award-id>602152</award-id>
          <award-id>602152</award-id>
          <award-id>602152</award-id>
          <principal-award-recipient>
            <name>
              <surname>Schwarzer</surname>
              <given-names>Johanna M.</given-names>
            </name>
            <name>
              <surname>Meyhoefer</surname>
              <given-names>Inga</given-names>
            </name>
            <name>
              <surname>Antonucci</surname>
              <given-names>Linda A.</given-names>
            </name>
            <name>
              <surname>Kambeitz-Ilankovic</surname>
              <given-names>Lana</given-names>
            </name>
            <name>
              <surname>Surmann</surname>
              <given-names>Marian</given-names>
            </name>
            <name>
              <surname>Bienek</surname>
              <given-names>Olga</given-names>
            </name>
            <name>
              <surname>Romer</surname>
              <given-names>Georg</given-names>
            </name>
            <name>
              <surname>Dannlowski</surname>
              <given-names>Udo</given-names>
            </name>
            <name>
              <surname>Dwyer</surname>
              <given-names>Dominic B.</given-names>
            </name>
            <name>
              <surname>Ruef</surname>
              <given-names>Anne</given-names>
            </name>
            <name>
              <surname>Rosen</surname>
              <given-names>Marlene</given-names>
            </name>
            <name>
              <surname>Lichtenstein</surname>
              <given-names>Theresa</given-names>
            </name>
            <name>
              <surname>Ruhrmann</surname>
              <given-names>Stephan</given-names>
            </name>
            <name>
              <surname>Kambeitz</surname>
              <given-names>Joseph</given-names>
            </name>
            <name>
              <surname>Salokangas</surname>
              <given-names>Raimo K. R.</given-names>
            </name>
            <name>
              <surname>Pantelis</surname>
              <given-names>Christos</given-names>
            </name>
            <name>
              <surname>Meisenzahl</surname>
              <given-names>Eva</given-names>
            </name>
            <name>
              <surname>Brambilla</surname>
              <given-names>Paolo</given-names>
            </name>
            <name>
              <surname>Bertolino</surname>
              <given-names>Alessandro</given-names>
            </name>
            <name>
              <surname>Borgwardt</surname>
              <given-names>Stefan</given-names>
            </name>
            <name>
              <surname>Upthegrove</surname>
              <given-names>Rachel</given-names>
            </name>
            <name>
              <surname>Koutsouleris</surname>
              <given-names>Nikolaos</given-names>
            </name>
            <name>
              <surname>Lencer</surname>
              <given-names>Rebekka</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001659</institution-id>
              <institution>Deutsche Forschungsgemeinschaft (German Research Foundation)</institution>
            </institution-wrap>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>Heisenberg Professur der DFG</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>European Unions Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No. 734227</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s), under exclusive licence to American College of Neuropsychopharmacology 2022</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p id="Par2">Perceptual deficits in terms of hallucinations are diagnostically indicative for psychotic disorders such as schizophrenia [<xref ref-type="bibr" rid="CR1">1</xref>] but may also occur at more subtle levels [<xref ref-type="bibr" rid="CR2">2</xref>]. Recent research emphasized dysfunctions within the visual system, specifically early visual processing impairments within the dorsal visual stream [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>], to be an important subject to study. About 50–60% of patients diagnosed with schizophrenia report visual dysfunctions (VisDys) affecting brightness, motion, form, color perception or distorted perception of one’s face (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>], in contrast to patients with non-psychotic disorders [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. These subtle VisDys are often underrecognized during clinical examination despite their clinical relevance related to suicidal ideation, cognitive impairment, or poorer treatment response [<xref ref-type="bibr" rid="CR5">5</xref>]. Studying VisDys and their neurobiological underpinnings could foster our understanding of basic disease mechanisms implicated in psychotic disorders [<xref ref-type="bibr" rid="CR5">5</xref>] as impairments of visual processing, e.g., decreased contrast sensitivity [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>], disturbed forward/backward masking [<xref ref-type="bibr" rid="CR11">11</xref>], decreased visual context surround suppression [<xref ref-type="bibr" rid="CR12">12</xref>], or general altered perceptual organization in schizophrenia [<xref ref-type="bibr" rid="CR13">13</xref>] have been reported from psychophysiological studies. Such dysfunctions may be explained by deficient optimization of response levels and other deficits of multiple visual integration along visual processing pathways in the brain [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>].<fig id="Fig1"><label>Fig. 1</label><caption><title>Prominent example of visual distortions illustrated by a patient with a psychotic disorder.</title><p>Copyright courtesy to the artist.</p></caption><graphic xlink:href="41386_2022_1385_Fig1_HTML" id="d32e1519"/></fig></p>
      <p id="Par3">Most studies about VisDys in schizophrenia included patients at a stable, chronic state of the illness. Furthermore, VisDys are also considered so-called basic symptoms being present even years before the diagnosis of a psychotic disorder [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. High-risk patients, who report VisDys, may be even more sensitive to convert to psychosis than those without VisDys [<xref ref-type="bibr" rid="CR17">17</xref>]. This suggests deeper insights into VisDys and their dynamic in early states of psychosis could hold beneficial information for clinical practice, and especially, on neurobiologically determined brain dysfunction mediating susceptibility to psychosis. However, only little research has focused on the neurobiological underpinnings of VisDys specifically in early states of psychosis and/or in comparison to other disorders, particularly depression [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR16">16</xref>].</p>
      <p id="Par4">The Personalised Prognostic Indicators for early Psychosis management (PRONIA, <ext-link ext-link-type="uri" xlink:href="https://www.pronia.eu">https://www.pronia.eu</ext-link>) consortium offers the unique chance to systematically study, first, the psychophysiological phenomenon of VisDys in a large sample of adolescents and young adults comprising three diagnosis groups: recent-onset psychosis (ROP), clinical high-risk state of psychosis (CHR) and recent-onset depression (ROD). VisDys in daily life were here assessed using the Schizophrenia Proneness Instrument-Adult Scale (SPI-A) [<xref ref-type="bibr" rid="CR6">6</xref>], an extensively validated and used scale to assess basic symptoms indicating increased risk to psychosis [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR18">18</xref>–<xref ref-type="bibr" rid="CR21">21</xref>]. Second, resting-state imaging data on intrinsic brain networks were also assessed in the PRONIA sample and analyzed based on work by Dosenbach et al. [<xref ref-type="bibr" rid="CR22">22</xref>]. This yielded 12,720 functional connectivities between 160 regions of interest (ROIs) across the whole brain comprising six subnetworks (cerebellum, cingulo-opercular, default, frontoparietal, sensorimotor and occipital). Regarding our interest in primary networks for visual information processing, especially the dorsal visual stream, we focused on two subnetworks, namely the occipital (ON) and frontoparietal (FPN) intrinsic networks. The ON was chosen for comprising primary visual processing pathways while the FPN is widely suggested to modulate attention related to visual information processing at higher cognitive levels [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>].</p>
      <p id="Par5">Provided the large PRONIA sample [<xref ref-type="bibr" rid="CR25">25</xref>], a multivariate pattern analysis approach was chosen to study the complex relationships between ON, FPN, and VisDys. This approach enables the consideration of multiple interactions within brain systems as required for the study of inherently heterogeneous collectives of mental disorders beyond clinical evaluation [<xref ref-type="bibr" rid="CR26">26</xref>]. In addition, this approach offers the opportunity to investigate the predictive value of these brain networks for the classification of VisDys presence or absence on an individual level.</p>
      <p id="Par6">Three major research questions drove our analyses. First, are VisDys specific to the psychosis spectrum at early stages of a mental disorder? Second, are VisDys associated with clinical characteristics, i.e., higher symptom load and worse functional outcome? Third, is functional intrinsic connectivity within ON and FPN related to the presence or absence of VisDys, and if so, are there differences in this relationship across the psychosis spectrum?</p>
    </sec>
    <sec id="Sec2">
      <title>Methods</title>
      <sec id="Sec3">
        <title>Sample characteristics</title>
        <p id="Par7">A total sample of 721 participants was drawn from the PRONIA database [<xref ref-type="bibr" rid="CR27">27</xref>], including 147 with ROP, 143 participants at CHR, 151 with ROD, and 280 HC. Participants were recruited through early detection units across seven European university sites [<xref ref-type="bibr" rid="CR27">27</xref>]. Written informed consent was obtained from all participants and from legal guardians for underage participants, respectively. Each site received ethical approval from their referring ethics committee conforming with the Helsinki Declaration [<xref ref-type="bibr" rid="CR27">27</xref>]. General inclusion criteria were age between 15 and 40 years, sufficient language skills for participation, and sufficient capacity to consent. General exclusion criteria included an IQ below 70, current or past neurological or somatic disorder of the brain including head trauma with loss of consciousness (&gt;5 min); any medical contraindications for MRI; current or past (past 6 months) alcohol or substance dependency.</p>
        <p id="Par8">Additionally, ROP participants had to meet the DSM-IV-TR criteria for an affective or non-affective psychotic episode within the last 3 months, with the start of psychotic symptoms within the 24 months preceding screening date. Exclusion criteria for ROP participants were any antipsychotic medication for longer than 90 days (within the past 24 months) with a daily dose rate at or above the minimum dosage of DGPPN S3-guidelines [<xref ref-type="bibr" rid="CR28">28</xref>]. Participants were excluded if psychotic symptoms were drug-induced and, therefore, abstinence of any drugs, including cannabis and alcohol, for at least 1 month, was mandatory.</p>
        <p id="Par9">A CHR state was alternatively defined by the basic symptom criterion “Cognitive Disturbances” [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR18">18</xref>] and any of the adapted PRONIA ultra-high-risk criteria [<xref ref-type="bibr" rid="CR27">27</xref>]. It was carefully checked through the questionnaire and in single case consensus conferences that diagnosis-defining criteria were not induced by drug use. Exclusion criteria specific to the CHR group included antipsychotic medication for more than 30 days and intake of antipsychotic medication within the past 3 months before baseline assessments at or above a minimum dosage of first-episode psychosis according to DGPPN S3-guideline [<xref ref-type="bibr" rid="CR28">28</xref>].</p>
        <p id="Par10">ROD participants had to meet the DSM-IV-TR Major Depressive Episode criteria within their lifetime and major depressive disorder (MDD) criteria within the past 3 months, while the duration of the first depressive episode must not exceed 24 months. Specific exclusion criteria for ROD participants were more than one MDD episode during the lifetime and the intake of antipsychotic medication analogous to the CHR exclusion criteria.</p>
        <p id="Par11">Exclusion criteria specific to HC participants included current or past DSM-IV-TR-Axis-I disorder; history of CHR criteria; affective or non-affective psychosis or major affective disorder of first-degree relatives, and intake of psychopharmacological substances.</p>
      </sec>
      <sec id="Sec4">
        <title>Clinical assessments</title>
        <p id="Par12">Fourteen items from the SPI-A were selected to represent different aspects of VisDys [<xref ref-type="bibr" rid="CR6">6</xref>] (Fig. <xref rid="Fig2" ref-type="fig">2a</xref> and Table <xref rid="MOESM1" ref-type="media">S1</xref>). Participants reported the severity of the respective VisDys defined by the maximum frequency within the past 3 months (0 = never, 6 = daily). A sum score was computed over the 14 SPI-A items for each participant individually as reported previously [<xref ref-type="bibr" rid="CR29">29</xref>]. Additionally, participants were categorized into two groups based on this sum score, i.e., VisDys<sup>+</sup> (sum score &gt; 0) and VisDys<sup>−</sup> (sum score = 0), respectively, for further analyses.<fig id="Fig2"><label>Fig. 2</label><caption><title>Summary of VisDys item means and underlying component structure by group.</title><p>Displays degrees of severity for each of the 14 VisDys items by group derived from SPI-A (<bold>a</bold>) and visualization of the number of components underlying VisDys sum score for ROP and CHR groups (scree plots from PCA analyses in <bold>b</bold>, <bold>c</bold>, respectively). For more details see Tables <xref rid="MOESM1" ref-type="media">S2</xref> and <xref rid="MOESM1" ref-type="media">S3</xref>.</p></caption><graphic xlink:href="41386_2022_1385_Fig2_HTML" id="d32e1672"/></fig></p>
        <p id="Par13">Other clinical assessments included the Beck Depression Inventory-II (BDI-II) [<xref ref-type="bibr" rid="CR30">30</xref>], the Positive and Negative Syndrome Scale (PANSS) [<xref ref-type="bibr" rid="CR31">31</xref>], the Functional Remission in General Schizophrenia (FROGS) [<xref ref-type="bibr" rid="CR32">32</xref>] scale (including daily life, social functioning, treatment subscales), the GF Role [<xref ref-type="bibr" rid="CR33">33</xref>] and GF Social [<xref ref-type="bibr" rid="CR34">34</xref>] for global role and social functioning, and the World Health Organization-Quality of Life (QoL) scale that includes the subscales physical, psychological, social relationships, and environment [<xref ref-type="bibr" rid="CR35">35</xref>].</p>
        <p id="Par14">Additionally, the Rey-Osterrieth Complex Figure Test whole score (ROCF) [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>], as a neuropsychological measurement of visuospatial constructability was assessed to study whether VisDys may be associated with the ability to see an object or picture as a set of parts and then construct a replica of the original from these parts [<xref ref-type="bibr" rid="CR38">38</xref>]. This was tested immediately (ROCF immediate) and 30 min (ROCF delayed) after the object presentation.</p>
      </sec>
      <sec id="Sec5">
        <title>Statistical analyses of clinical data</title>
        <p id="Par15">Demographic characteristics, behavioral data, and VisDys parameters were compared between groups using one-way ANOVAs, <italic>X</italic><sup>2</sup><italic>-</italic>tests, and crosstabs. Principal component analysis (PCA) with orthogonal rotation (varimax) was applied on SPI-A items in groups separately. VisDys sum scores were correlated with clinical measures using nonparametric correlations with Kendall’s Tau (<italic>τ</italic>).</p>
        <p id="Par16">Depending on the number of group comparisons (HC-ROD, HC-CHR, HC-ROP, ROD-CHR, ROD-ROP, CHR-ROP resulting in six comparisons) and subscales of each measurement we corrected for multiple testing using Bonferroni–Holm-corrected alpha levels [<xref ref-type="bibr" rid="CR39">39</xref>], corrected <italic>p</italic> values are reported throughout.</p>
      </sec>
      <sec id="Sec6">
        <title>Assessment and analyses of resting-state activity</title>
        <p id="Par17">To facilitate the evaluation of real-world generalizability, a minimal MRI harmonization protocol was implemented across all PRONIA-sites. While acquiring brain resting-state activity, subjects were instructed to keep their eyes open and not to think about anything. For details including preprocessing and analyses of resting-state MRI see Supplementary Material and ref. [<xref ref-type="bibr" rid="CR40">40</xref>].</p>
        <p id="Par18">Based on our a priori hypothesis, we focused on ROIs associated with intrinsic brain networks as defined by the Dosenbach functional atlas [<xref ref-type="bibr" rid="CR22">22</xref>] which are involved in primary visual processing along the dorsal visual stream. This resulted in ON (<italic>N</italic> = 22 ROIs) and FPN (<italic>N</italic> = 21 ROIs, Table <xref rid="MOESM1" ref-type="media">S4</xref>), comprising 231 pairwise connectivities for ON, 210 connectivities for FPN, and 903 connectivities for combined ON-FPN (Tables <xref rid="MOESM1" ref-type="media">S3</xref>, <xref rid="MOESM2" ref-type="media">S9</xref>–<xref rid="MOESM5" ref-type="media">S12</xref>).</p>
      </sec>
      <sec id="Sec7">
        <title>Machine-learning analyses</title>
        <p id="Par19">A total of 135 ROP, 128 CHR, and 134 ROD participants, for whom rsfMRI was available, were entered in the pipeline. Since prevalence of VisDys in HC was very low, HC were excluded from this approach.</p>
        <p id="Par20">For multivariate pattern analysis we used the NeuroMiner software (version 1.0; <ext-link ext-link-type="uri" xlink:href="http://www.proniapredictors.eu/neurominer/index.html">www.proniapredictors.eu/neurominer/index.html</ext-link>) for the classification of VisDys<sup>−</sup> vs. VisDys<sup>+</sup> indicating the absence or presence of VisDys within the past 3 months based on resting-state network connectivities in ON and FPN as defined above. Individual models for each of the groups (ROP, CHR, ROD) were trained and parameters were optimized using a repeated nested leave-one-site-out cross-validation design [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. Thus, hyperparameter optimization was done within an inner cross-validation cycle (CV1; 6 folds) and, subsequently, the best performing model was applied to an outer CV cycle (CV2; 7 folds/study sites). Thus, in each CV2 cycle one study site was held out to generate geographical generalization [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. To better identify connections across groups possibly associated with VisDys, we extracted the cross-validation ratio (CVR) for each connectivity in each group for each intrinsic network (for details on CVR and the machine-learning pipeline see Supplementary Material).</p>
      </sec>
    </sec>
    <sec id="Sec8" sec-type="results">
      <title>Results</title>
      <sec id="Sec9">
        <title>Clinical characteristics of the sample</title>
        <p id="Par21">Compared to the HC group, ROP, CHR, and ROD scored lower on clinical parameters measuring Qol and Global Functioning (Table <xref rid="Tab1" ref-type="table">1</xref>). Furthermore, all patient groups expressed a higher level of depression, i.e., BDI-II scores, and performed lower on the visuospatial ability task.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Sociodemographic and clinical characteristics of the original sample (shown are numbers or means with standard deviation (SD), respectively).</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>HC</th><th>ROD</th><th>CHR</th><th>ROP</th><th>Statistics</th></tr><tr><th><italic>N</italic><sup>e</sup></th><th>280</th><th>151</th><th>143</th><th>147</th><th/></tr></thead><tbody><tr><td>Age (SD)</td><td>28.54 (6.43)<sup>c</sup></td><td>29.13 (6.22)<sup>c</sup></td><td>26.97 (4.98)<sup>b</sup></td><td>28.45 (5.53)</td><td><italic>F</italic>(3,717) = 3.57, <italic>p</italic> = 0.014</td></tr><tr><td>Sex (m:w)</td><td>110:170<sup>d</sup></td><td>71:80<sup>d</sup></td><td>72:71</td><td>89:58<sup>a,b</sup></td><td><italic>X</italic><sup>2</sup>(3, <italic>N</italic> = 721) = 18.08, <italic>p</italic> = 4.22e−4</td></tr><tr><td>VisDys Prevalence (±)</td><td>4.28% (12/268)<sup>b,c,d</sup></td><td>16.56% (25/126)<sup>a,c,d</sup></td><td>55.94% (80/63)<sup>a,b</sup></td><td>50.34% (74/73) <sup>a,b</sup></td><td><italic>X</italic><sup>2</sup>(3, <italic>N</italic> = 721) = 185.19, <italic>p</italic> = 6.67e−40</td></tr><tr><td>VisDys sum score (SD)</td><td>0.08 (0.39)<sup>c,d</sup></td><td>0.64 (2.06)<sup>c,d</sup></td><td>3.85 (5.71)<sup>a,b</sup></td><td>4.46 (8.91)<sup>a,b</sup></td><td><italic>F</italic>(3,717) = 37.92, <italic>p</italic> = 9.44e−23</td></tr><tr><td>WHOQOL physical (SD)</td><td>17.64 (1.67)<sup>b,c,d</sup></td><td>12.86 (2.83)<sup>a,d</sup></td><td>13.00 (2.38)<sup>a</sup></td><td>13.63 (2.60)<sup>a,b</sup></td><td><italic>F</italic>(3,648) = 204.62, <italic>p</italic> = 2.37e−93</td></tr><tr><td>WHOQOL psychological (SD)</td><td>16.38 (2.05)<sup>b,c,d</sup></td><td>10.47 (2.75)<sup>a,d</sup></td><td>10.59 (3.03)<sup>a,d</sup></td><td>12.14 (3.12)<sup>a,b,c</sup></td><td><italic>F</italic>(3,654) = 226.32, <italic>p</italic> = 1.11e−100</td></tr><tr><td>WHOQOL social (SD)</td><td>16.04 (2.65)<sup>b,c,d</sup></td><td>12.33 (3.47)<sup>a</sup></td><td>12.32 (3.62)<sup>a</sup></td><td>12.66 (3.58)<sup>a</sup></td><td><italic>F</italic>(3,642) = 65.31, <italic>p</italic> = 7.26e−37</td></tr><tr><td>WHOQOL environmental (SD)</td><td>16.71 (1.84)<sup>b,c,d</sup></td><td>14.45 (2.54)<sup>a</sup></td><td>14.19 (2.24)<sup>a</sup></td><td>13.94 (2.61)<sup>a</sup></td><td><italic>F</italic>(3,652) = 67.98, <italic>p</italic> = 2.94e−38</td></tr><tr><td>FROGS DailyLife (SD)</td><td>–</td><td>20.80 (4.67)</td><td>19.41 (4.43)<sup>d</sup></td><td>20.08 (4.72)<sup>c</sup></td><td><italic>F</italic>(2,433) = 21.01, <italic>p</italic> = 1.96e−9</td></tr><tr><td>FROGS Activities (SD)</td><td>–</td><td>11.98 (3.16)<sup>d</sup></td><td>8.87 (3.50)<sup>d</sup></td><td>10.32 (3.22)<sup>b,c</sup></td><td><italic>F</italic>(2,433) = 13.59, <italic>p</italic> = 2.00e−6</td></tr><tr><td>FROGS Relationships (SD)</td><td>–</td><td>20.35 (4.64)<sup>d</sup></td><td>17.03 (4.27)<sup>d</sup></td><td>18.04 (4.77)<sup>b,c</sup></td><td><italic>F</italic>(2,433) = 19.38, <italic>p</italic> = 8.63e−9</td></tr><tr><td>FROGS Health and Treatment (SD)</td><td>–</td><td>12.58 (2.62)</td><td>11.31 (2.51)</td><td>11.72 (2.80)</td><td><italic>F</italic>(2,432) = 16.37, <italic>p</italic> = 1.41e−7</td></tr><tr><td>PANSS pos (SD)</td><td>–</td><td>7.66 (1.24)<sup>c,d</sup></td><td>10.17 (3.16)<sup>b,d</sup></td><td>17.51 (6.36)<sup>b,c</sup></td><td><italic>F</italic>(2,433) = 223.16, <italic>p</italic> = 2.46e−67</td></tr><tr><td>PANSS neg (SD)</td><td>–</td><td>12.27 (4.79)<sup>d</sup></td><td>12.20 (5.77)<sup>d</sup></td><td>16.47 (7.89)<sup>b,c</sup></td><td><italic>F</italic>(2,433) = 22.01, <italic>p</italic> = 7.90e−10</td></tr><tr><td>PANSS gen (SD)</td><td>–</td><td>26.95 (6.55)<sup>d</sup></td><td>27.74 (7.12)<sup>d</sup></td><td>35.64 (11.01)<sup>b,c</sup></td><td><italic>F</italic>(2,431) = 46.89, <italic>p</italic> = 2.85e−19</td></tr><tr><td>ROCF whole (SD)</td><td>34.56 (1.88)<sup>d</sup></td><td>33.98 (2.78)</td><td>34.14 (2.71)</td><td>33.30 (3.89)<sup>a</sup></td><td><italic>F</italic>(3,696) = 6.78, <italic>p</italic> = 1.65e−4</td></tr><tr><td>ROCF immediate (SD)</td><td>24.71 (5.57)<sup>c,d</sup></td><td>23.76 (6.12)<sup>d</sup></td><td>22.84 (6.50)<sup>a,d</sup></td><td>19.57 (7.09)<sup>a,b,c</sup></td><td><italic>F</italic>(3,696) = 22.15, <italic>p</italic> = 1.05e−13</td></tr><tr><td>ROCF delayed (SD)</td><td>24.75 (5.31)<sup>c,d</sup></td><td>23.63 (6.15)<sup>d</sup></td><td>22.24 (6.41)<sup>a,d</sup></td><td>19.72 (6.91)<sup>a,b,c</sup></td><td><italic>F</italic>(3,696) = 23.00, <italic>p</italic> = 3.77e−14</td></tr><tr><td>BDI-II (SD)</td><td>3.67 (5.24)<sup>b,c,d</sup></td><td>25.85 (13.98)<sup>a,d</sup></td><td>25.75 (12.24)<sup>a,d</sup></td><td>21.91 (12.61)<sup>a,b,c</sup></td><td><italic>F</italic>(3,659) = 212.69, <italic>p</italic> = 8.61e−98</td></tr><tr><td>GF Role (SD)</td><td>8.55 (0.75)<sup>b,c,d</sup></td><td>6.24 (1.61)<sup>a,d</sup></td><td>6.18 (1.42)<sup>a,d</sup></td><td>5.19 (1.71)<sup>a,b,c</sup></td><td><italic>F</italic>(3,712) = 252.89, <italic>p</italic> = 2.97e−114</td></tr><tr><td>GF Social (SD)</td><td>8.51 (0.82)<sup>b,c,d</sup></td><td>6.46 (1.32)<sup>a,d</sup></td><td>6.47 (1.30)<sup>a,d</sup></td><td>5.63 (1.51)<sup>a,b,c</sup></td><td><italic>F</italic>(3,712) = 232.52, <italic>p</italic> = 1.91e−107</td></tr></tbody></table><table-wrap-foot><p>Indicate significant differences with <italic>p</italic> &lt; 0.05 revealed in post hoc analyses compared to: a = HC; b = ROD; c = CHR; d = ROP, for details see text. Positive and Negative Syndrome Scale: -positive scale (PANSS pos), -negative scale (PANSS neg), -general scale (PANSS gen); Beck Depression Inventory-II (BDI-II); World Health Organization Quality of life: -physical subscale (WHOQOL physical), -psychological subscale (WHOQOL psychological), -social subscale (WHOQOL social), -environmental subscale (WHOQOL environmental); Functional Remission of General Schizophrenia: -daily life subscale (FROGS_DailyLife), -activities subscale (FROGS Activities), -relationships subscale (FROGS Relationships), -health and treatment subscale (FROGS Health and Treatment); Rey-Osterrieth Complex Figure Test: -whole score (ROCF whole), -immediate Score (ROCF immediate), -delayed score (ROCF delayed); Global functioning: -role level (GF Role), -social level (GF Social).</p><p><sup>e</sup><italic>N</italic> where VisDys data were available.</p></table-wrap-foot></table-wrap></p>
        <p id="Par22">Comparisons of clinical measures between ROP and CHR, the two groups showing similarly high VisDys prevalence rates and severity (Table <xref rid="Tab1" ref-type="table">1</xref>), indicate ROP expressing higher symptom severity on all PANSS subscales and lower functional remission, i.e., FROGS subscales, and overall functioning, i.e., GF Role and GF Social scales. Regarding visuospatial ability (ROCF), ROP patients performed weaker compared to CHR. On the other hand, ROP participants compared to CHR showed less depressive symptom expression on BDI-II and reported higher levels of Qol (WHOQOL, psychological scale, Table <xref rid="MOESM1" ref-type="media">S5</xref>). Note, in both groups, higher BDI scores were associated with lower WHOQOL scores, specifically WHOQOL-subscores physical and psychological in CHR and all WHOQOL scores in ROP.</p>
      </sec>
      <sec id="Sec10">
        <title>VisDys characteristics across groups</title>
        <p id="Par23">VisDys prevalence was higher in groups belonging to the psychosis spectrum, i.e., ROP (50.34%) and CHR (55.94%), compared with ROD (16.56%) and HC (4.28%; ROP = CHR &gt; ROD = HC) (Table <xref rid="Tab1" ref-type="table">1</xref>). In line with this, VisDys sum scores in ROP and CHR were also higher than in ROD and HC. Note, VisDys sum scores showed high internal consistency (Cronbachs alpha = 0.78 over all subjects, <italic>n</italic> = 721).</p>
        <p id="Par24">Detailed evaluation of individual SPI-A items by PCA (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>) revealed different characteristics across the groups (ROP: KMO (Kaiser–Meyer–Olkin criterion) = 0.75, Bartlett’s test of sphericity <italic>χ</italic><sup>2</sup>(91) = 702.47, <italic>p</italic> &lt; 0.001; CHR: KMO = 0.58, Bartlett’s test of sphericity <italic>χ</italic><sup>2</sup> (91) = 347.76, <italic>p</italic> &lt; 0.001). In the ROP group, four components had eigenvalues over KMO of 1 but the scree plot inflection point justified retaining one major component (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>). In the CHR group, five components had eigenvalues over Kaiser’s criterion of 1 but the scree plot inflection point supported to retain three components (Fig. <xref rid="Fig2" ref-type="fig">2c</xref>).</p>
        <p id="Par25">As the CHR group presented to be heterogeneous, subjects were subsequently assigned to subgroups according to the highest PCA loading factor following an exploratory approach (Supplementary Material). PCA was not performed in ROD and HC due to low VisDys prevalence rates.</p>
      </sec>
      <sec id="Sec11">
        <title>Associations between VisDys and clinical measures</title>
        <p id="Par26">In ROP, higher VisDys sum score correlated with lower score for functional remission (FROGS-daily life, <italic>τ</italic> = −0.150, <italic>p</italic> = 0.036) and GF Social (<italic>τ</italic> = −0.180, <italic>p</italic> = 0.014) (Table <xref rid="MOESM1" ref-type="media">S6</xref>).</p>
        <p id="Par27">In CHR, higher VisDys sum scores were associated with lower scores for health-related functional remission (FROGS-Health and Treatment subscale (<italic>τ</italic> = −0.162, <italic>p</italic> = 0.024)), and lower Qol (WHOQOL-physical subscale: <italic>τ</italic> = −0.213, <italic>p</italic> = 0.004; WHOQOL-psychological subscale: <italic>τ</italic> = −0.173, <italic>p</italic> = 0.015). Higher VisDys sum scores were further associated with more severe depression on BDI-II (<italic>τ</italic> = 0.149, <italic>p</italic> = 0.021). Follow-up partial correlation analyses, controlling for BDI-II revealed the extent of depressiveness did not affect the association between VisDys and Qol in CHR, particularly on the physical sublevel (Table <xref rid="MOESM1" ref-type="media">S7</xref>). Finally, higher VisDys sum scores in CHR were associated with more impaired visuospatial constructability (ROCF-whole, <italic>τ</italic> = −0.162, <italic>p</italic> = 0.027 and ROCF-delayed scores, <italic>τ</italic> = −0.130, <italic>p</italic> = 0.038).</p>
        <p id="Par28">In ROD and HC groups, no relevant correlations were found between VisDys sum scores and any parameters representing functional remission, Qol, depressiveness, or visuospatial constructability (Supplementary Material).</p>
      </sec>
      <sec id="Sec12">
        <title>Predicting VisDys by functional connectivity in ON and FPN</title>
        <p id="Par29">The machine-learning and the original sample showed similar profiles regarding clinical characteristics and symptom expression (Table <xref rid="MOESM1" ref-type="media">S8</xref>). Specific characteristics of the best models predicting VisDys as revealed by multivariate pattern analyses are presented in Table <xref rid="Tab2" ref-type="table">2</xref>.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Specification of machine-learning results.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Analysis</th><th>BAC (%)</th><th>Accuracy (%)</th><th>Sensitivity (%)</th><th>Specificity (%)</th><th>AUC</th><th>PPV (%)</th><th>NPV (%)</th><th><italic>p</italic> value</th></tr></thead><tbody><tr><td>ON_ROP</td><td>60.17</td><td>60.00</td><td>80.59</td><td>39.74</td><td>0.59</td><td>56.84</td><td>67.50</td><td><bold>0.0001</bold></td></tr><tr><td>ON_CHR</td><td>67.38</td><td>65.62</td><td>44.93</td><td>89.83</td><td>0.69</td><td>83.78</td><td>58.24</td><td><bold>0.029</bold></td></tr><tr><td>ON_ROP + CHR</td><td>55.89</td><td>55.51</td><td>44.85</td><td>66.92</td><td>0.62</td><td>59.22</td><td>53.13</td><td>0.221</td></tr><tr><td>ON_ROD</td><td>51.57</td><td>76.86</td><td>13.04</td><td>90.09</td><td>0.46</td><td>21.43</td><td>83.33</td><td>0.360</td></tr><tr><td>FPN_ROP</td><td>52.67</td><td>52.59</td><td>64.18</td><td>41.18</td><td>0.57</td><td>51.81</td><td>53.85</td><td>0.250</td></tr><tr><td>FPN_CHR</td><td>63.02</td><td>61.72</td><td>46.37</td><td>79.66</td><td>0.67</td><td>72.73</td><td>55.95</td><td>0.100</td></tr><tr><td>FPN_ROP + CHR</td><td>61.11</td><td>60.84</td><td>52.94</td><td>69.29</td><td>0.66</td><td>64.86</td><td>57.89</td><td><bold>0.006</bold></td></tr><tr><td>FPN_ROD</td><td>47.67</td><td>76.12</td><td>4.35</td><td>90.99</td><td>0.51</td><td>9.09</td><td>82.11</td><td>0.700</td></tr><tr><td>ON-FPN_ROP</td><td>56.46</td><td>56.29</td><td>79.11</td><td>33.82</td><td>0.59</td><td>54.08</td><td>62.16</td><td>0.222</td></tr><tr><td>ON-FPN_CHR</td><td>62.77</td><td>61.72</td><td>49.28</td><td>76.27</td><td>0.64</td><td>70.83</td><td>56.25</td><td>0.122</td></tr><tr><td>ON-FPN_ROP + CHR</td><td>59.69</td><td>59.32</td><td>48.53</td><td>70.86</td><td>0.64</td><td>64.07</td><td>56.25</td><td><bold>0.016</bold></td></tr><tr><td>ON-FPN_ROD</td><td>41.28</td><td>62.68</td><td>8.69</td><td>73.87</td><td>0.37</td><td>6.45</td><td>79.61</td><td>0.956</td></tr></tbody></table><table-wrap-foot><p>Significant <italic>p</italic> values are printed in bold type.</p><p><italic>ON</italic> occipital network, <italic>FPN</italic> frontoparietal network, <italic>ON-FPN</italic> occipital and frontoparietal network combined, <italic>CHR</italic> clinical high risk for psychosis, <italic>ROP</italic> recent onset of psychosis, <italic>ROP</italic> <italic>+</italic> <italic>CHR</italic> combined group of ROP and CHR, <italic>ROD</italic> recent onset of depression, <italic>BAC</italic> balanced accuracy, <italic>AUC</italic> area under the curve, <italic>PPV</italic> positive predictive value, <italic>NPV</italic> negative predictive values.</p></table-wrap-foot></table-wrap></p>
        <p id="Par30">In ROP, the model correctly classified recent VisDys<sup>+</sup> from VisDys<sup>−</sup> based on ON connectivity with a BAC of 60.17% (<italic>p</italic> = 0.0001). Sensitivity of the ROP model was high indicating high rates of true predictions of VisDys<sup>+</sup> based on connectivities in ON whereas specificity was low (Table <xref rid="Tab2" ref-type="table">2</xref>). In CHR, the referring BAC was 67.38% (<italic>p</italic> = 0.029). Here, high specificity indicates high rates of true predictions of VisDys<sup>–</sup> based on ON connectivity, whereas sensitivity was low (for results regarding the combined ROP + CHR sample see Table <xref rid="Tab2" ref-type="table">2</xref>).</p>
        <p id="Par31">To investigate whether the associations of functional brain alterations with VisDys were similar across disorder groups, we applied the ROP model on the CHR group and vice versa. For both ON and FPN, this was not successful. We also tested the ON-ROP model on the three individual CHR subgroups established by PCA (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>, c and Tables <xref rid="MOESM1" ref-type="media">S2</xref> and <xref rid="MOESM1" ref-type="media">S3</xref>). By this exploratory approach, the ON-ROP model correctly identified 9/12 (75.00%) of VisDys<sup>+</sup> probands in CHR-subgroup 1, 16/19 (84.21%) in CHR-subgroup 2, and 19/30 (63.33%) in CHR-subgroup 3 suggesting that the relationships between VisDys and ON in CHR-subgroup 2 may be similar to ROP.</p>
        <p id="Par32">The most relevant functional connectivities contributing to the prediction of VisDys are illustrated in Fig. <xref rid="Fig3" ref-type="fig">3</xref> (for a complete list of CVRs see Tables <xref rid="MOESM2" ref-type="media">S9</xref>–<xref rid="MOESM5" ref-type="media">S12</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><title>Most reliable intrinsic brain activity connectivities predicting visual dysfunctions.</title><p>Connectivities (lines) between regions of interest (spheres) derived from resting-state brain activity were identified as classifying the occurrence of visual dysfunctions (VisDys<sup>+</sup> vs. VisDys<sup>–</sup>) in patients with recent onset psychosis (ROP) and subjects at clinical high risk (CHR). Depicted are the most reliable connectivities, within the occipital network (ON) in ROP (<bold>a</bold>) and CHR groups (<bold>b</bold>). For the combined ROP + CHR group, connectivities within the frontoparietal network (FPN) and the combined ON-FPN are shown in <bold>c</bold>, <bold>d</bold>, respectively. For a list of all cross-validation ratios (CVs) see Tables <xref rid="MOESM2" ref-type="media">S9</xref>–<xref rid="MOESM5" ref-type="media">S12</xref>.</p></caption><graphic xlink:href="41386_2022_1385_Fig3_HTML" id="d32e3176"/></fig></p>
        <p id="Par33">No significant models predicting VisDys in ROD were established (Table <xref rid="Tab2" ref-type="table">2</xref>). Additionally, the application of significant models revealed in ROP and CHR did not yield any significant predictions in the ROD group.</p>
      </sec>
    </sec>
    <sec id="Sec13" sec-type="discussion">
      <title>Discussion</title>
      <p id="Par34">This study was driven by three major questions:</p>
      <sec id="Sec14">
        <title>Are VisDys specific to the psychosis spectrum at early stages of a mental disorder?</title>
        <p id="Par35">The main findings from this large sample study support the idea of VisDys being specific to the psychosis spectrum already at early stages, i.e., ROP and CHR, while VisDys were reported much less frequent in ROD, and appeared negligible in HC. Thus, our findings add to previous reports on patients with stable states of schizophrenia [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>] including similar VisDys sum score levels reported recently from schizophrenia patients in an independent study using the same SPI-A items for VisDys representation [<xref ref-type="bibr" rid="CR29">29</xref>]. VisDys have been also reported in CHR as they are regarded as basic symptoms mediating susceptibility to psychosis [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR47">47</xref>–<xref ref-type="bibr" rid="CR54">54</xref>]. Interestingly, we found higher heterogeneity among individual VisDys phenomena in CHR than ROP, while overall VisDys severity in VisDys<sup>+</sup> participants was similar in both groups. This constellation of findings suggests that the phenomenon of VisDys should be regarded differently in CHR and ROP as clinical impact and even neurobiological dysfunctions driving the phenomenon of VisDys might differ across psychosis spectrum groups.</p>
      </sec>
      <sec id="Sec15">
        <title>Are VisDys associated with clinical characteristics?</title>
        <p id="Par36">Previously, VisDys have been associated with lower overall functioning, poorer treatment response [<xref ref-type="bibr" rid="CR2">2</xref>], and higher suicidal ideation in schizophrenia [<xref ref-type="bibr" rid="CR55">55</xref>]. In our sample, ROP patients were clinically more impaired than CHR participants as reflected by higher PANSS-scores, lower functional remission (FROGS) and overall lower functioning (GF-subscales) in ROP. However, in both ROP and CHR higher VisDys sum scores correlated with lower functional remission, suggesting that VisDys may indicate an impaired ability to take care of oneself and being an independent member of society [<xref ref-type="bibr" rid="CR32">32</xref>].</p>
        <p id="Par37">Additionally, CHR patients reporting higher VisDys severity showed decreased Qol, an association not seen in ROP patients. This finding suggests greater susceptibility to effects of VisDys on subjective well-being in CHR than ROP. Note, CHR patients generally reported lower levels of Qol compared with ROP. This in turn could be explained by higher suffering from depressive symptoms (BDI-II-scores) in CHR patients, possibly affecting Qol [<xref ref-type="bibr" rid="CR56">56</xref>]. However, while BDI-II could explain the group differences regarding Qol, the extent of depressiveness did not affect the association between VisDys and Qol in CHR, particularly on the physical subscale.</p>
        <p id="Par38">Additionally, VisDys in CHR were associated to impaired visuospatial constructability (ROCF-whole score), a specific impairment affecting the ability to deconstruct a visual object into set of parts and to then construct a replica from these parts. This finding adds to previous work reporting associations between visual distortions and impaired cognition more generally [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. The absence of this association in ROP might be explained by both, generally stronger impairment of visuospatial constructability and stronger symptom expression of positive symptoms in ROP than CHR, possibly overshadowing associations with VisDys severity.</p>
        <p id="Par39">Together, the associations of VisDys with lower levels of functioning, Qol and cognitive function in CHR highlight the importance of beneficial interventions in this group [<xref ref-type="bibr" rid="CR56">56</xref>] with VisDys possibly representing a warning sign for early intervention.</p>
      </sec>
      <sec id="Sec16">
        <title>Is functional intrinsic connectivity within ON and FPN related to VisDys and if so, are there differences in this relationship across the psychosis spectrum?</title>
        <p id="Par40">Only little is known about underlying neurobiological processes leading to or being associated with VisDys. Originating in the retina, visual processing streams pass through the thalamus to the primary visual cortex in occipital cortex (ON). From there visual information is processed along either the dorsal stream to parietal areas, which form part of frontoparietal networks (FPN), or along the ventral stream involving more temporal regions [<xref ref-type="bibr" rid="CR3">3</xref>]. While the dorsal stream, primarily from magnocellular layers, is generally for initial attentional capture and processing of overall stimulus organization, the ventral stream, primarily from parvocellular layers, processes fine-gained stimulus details and serves for object identification [<xref ref-type="bibr" rid="CR3">3</xref>]. Note, both streams are highly interconnected [<xref ref-type="bibr" rid="CR59">59</xref>]. Additionally, bottom-up visual information processing is modulated by top-down control from higher-order frontal networks [<xref ref-type="bibr" rid="CR23">23</xref>].</p>
        <p id="Par41">In schizophrenia, previous research highlights abnormalities of visual information processing along both visual streams including retinal dysfunctions with a predominance of alterations observed related to the dorsal visual stream [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR60">60</xref>–<xref ref-type="bibr" rid="CR62">62</xref>]. For instance, basic visual symptoms correlated with rapid visual processing and magnocellular pathway function [<xref ref-type="bibr" rid="CR63">63</xref>]. From functional brain imaging studies with active task performance, hyper- and hypoactivations in multiple brain areas, including occipital, temporal, parietal, and frontal areas have been reported in schizophrenia, and CHR states [<xref ref-type="bibr" rid="CR64">64</xref>], which may explain the VisDys phenomenon [<xref ref-type="bibr" rid="CR65">65</xref>]. For intrinsic, resting-state brain activity, decreased coupling in salience network, dorsostriatal, superior temporal areas have been shown in CHR [<xref ref-type="bibr" rid="CR65">65</xref>]. Independently from mental states, visual hallucinations in blind probands have been linked to a build-up of resting-state neural activity in early visual systems [<xref ref-type="bibr" rid="CR66">66</xref>], another study found visual disruptions such as micropsia and macropsia to be linked to alterations in ON and FPN [<xref ref-type="bibr" rid="CR67">67</xref>].</p>
        <p id="Par42">Our large sample study is among the first to approach the VisDys phenomenon in early psychosis states using a multivariate machine-learning approach based on intrinsic brain connectivity as it allows investigating patterns of multivariable characteristics within brain systems related to VisDys [<xref ref-type="bibr" rid="CR25">25</xref>]. This approach identified two different predictive ON-models for ROP and CHR, respectively. The ON-model in ROP showed high sensitivity (80.59%) suggesting ON connectivities served well to identify VisDys<sup>+</sup> participants correctly, however specificity of this model was low. In contrast, the ON-model in CHR showed high specificity (89.83%), but low sensitivity suggesting ON connectivities rather identified VisDys<sup>−</sup> among CHR participants. Application of the individual ON-ROP model to CHR and vice versa was not successful, underlining the differences between CHR and ROP regarding the relationship between ON and VisDys. This observation adds to the different relations between VisDys and clinical measures in these groups discussed above. However, the exploratory finding that in one of the three CHR subgroups (i.e., component 2, Table <xref rid="MOESM1" ref-type="media">S3</xref>), the ROP model correctly identified 16 of 19 subjects with VisDys<sup>+</sup>, also suggests that this CHR-subgroup is similar to ROP regarding neurobiological underpinnings of VisDys.</p>
        <p id="Par43">Interestingly, we yielded two additional predictive models for VisDys across ROP + CHR groups, both involving the FPN. The FPN is regarded as mediating sustained attention, including visuospatial attention processed in parietal areas, for cognitively demanding tasks to frontal areas [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. Thus, while ROP and CHR differed in their relations between VisDys and ON, this constellation of findings suggests common alterations of visual information processing related to VisDys across both groups at higher-order cortical levels. In line with this, resistance to the phenomenon of depth inversion illusions in patients with schizophrenia and CHR-state has been hypothesized to reflect reduced constraints of higher-order top-down control in frontoparietal networks during visual perception [<xref ref-type="bibr" rid="CR68">68</xref>–<xref ref-type="bibr" rid="CR70">70</xref>].</p>
        <p id="Par44">In contrast to these findings in ROP and CHR, we did not find any evidence for functional connectivities in ON and FPN being related to VisDys in ROD supporting the notion that disturbances of visual information processing related to intrinsic ON and FPN are indicative of disease mechanisms in psychotic disorders.</p>
      </sec>
      <sec id="Sec17">
        <title>Limitations</title>
        <p id="Par45">First, CHR and ROP differed in age in the machine-learning sample, which was controlled by using age as a covariate in these analyses. Yet, both groups were mainly above the age threshold of 18 years reported to be relevant to the prevalence of VisDys [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>], thus, this age difference likely did not affect our results. Second, an independent sample for external ROP-ROP and CHR-CHR validation would have been beneficial and should be subject to future studies. Third, our study did not incorporate psychophysiological experiments to characterize VisDys but relied solely on subjective reports from patients. Fourth, as VisDys are subtle symptoms, future studies should also consider visual hallucinations to capture a broader range of alterations within the visual system. Fifth, despite careful examination, we cannot fully exclude that VisDys reported by patients were caused by organic factors or retinal dysfunctions not evaluated by the PRONIA protocol, which may be the case despite the young age of participants. Sixth, as we could not fully control subjects’ mental activity during resting-state assessment, general group differences in resting-state activities affecting the association with VisDys could be plausible.</p>
        <p id="Par46">To conclude, subtle VisDys should be regarded a frequent phenomenon across the psychosis spectrum, impinging negatively on patients’ current ability to function in several settings of their daily and social life, their Qol and visuospatial abilities. As these parameters are crucial for patients’ future well-being, it is essential to seriously consider VisDys in the clinical setting, especially in CHR.</p>
        <p id="Par47">Our multivariate findings offer novel insights into possible underlying biological mechanisms associated with VisDys, supporting previous models of dysfunctions within occipital and frontoparietal networks implicated in disease mechanisms of psychotic disorders. However, VisDys should be regarded differently in CHR and ROP requiring future studies to decipher characteristics specific to CHR and ROP in the association of VisDys with visual brain system function and dysfunction.</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary information</title>
      <sec id="Sec18">
        <p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41386_2022_1385_MOESM1_ESM.docx"><caption><p>Supplementary material VisDys PRONIA rev final</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41386_2022_1385_MOESM2_ESM.xlsx"><caption><p>Table S9 ON_ROP_75th percentile</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41386_2022_1385_MOESM3_ESM.xlsx"><caption><p>Table S10 ON_CHR_75th percentile</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41386_2022_1385_MOESM4_ESM.xlsx"><caption><p>Table S11 FPN_ROP+CHR_75th percentile</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="41386_2022_1385_MOESM5_ESM.xlsx"><caption><p>Table S12 ON-FPN_ROP+CHR_99th percentile</p></caption></media></supplementary-material>
</p>
      </sec>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
      </fn>
      <fn>
        <p>A list of authors and their affiliations appears at the end of the paper.</p>
      </fn>
    </fn-group>
    <sec>
      <title>Supplementary information</title>
      <p>The online version contains supplementary material available at 10.1038/s41386-022-01385-3.</p>
    </sec>
    <ack>
      <title>Acknowledgements</title>
      <p><italic>The PRONIA consortium</italic>: Principal investigator and primary contact is Prof. Nikolaos Koutsouleris (nikolaos.koutsouleris@med.uni-muenchen.de). PRONIA consortium members listed here performed the screening, recruitment, rating, examination, and follow-up of the study participants and were involved in implementing the examination protocols of the study, setting up its information technological infrastructure, and organizing the flow and quality control of the data analyzed in this article between the local study sites and the central study database. <italic>Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany:</italic> Alkomiet Hasan, Claudius Hoff, Ifrah Khanyaree, Aylin Melo, Susanna Muckenhuber-Sternbauer, Yanis Köhler, Ömer Öztürk, Nora Penzel, David Popovic, Adrian Rangnick, Sebastian von Saldern, Rachele Sanfelici, Moritz Spangemacher, Ana Tupac, Maria Fernanda Urquijo, Johanna Weiske, Antonia Wosgien, Camilla Krämer. <italic>Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany:</italic> Karsten Blume, Dominika Julkowski, Nathalie Kaden, Ruth Milz, Alexandra Nikolaides, Mauro, Silke Vent, Martina Wassen. <italic>Department of Psychiatry (Psychiatric University Hospital, UPK), University of Basel, Switzerland:</italic> Christina Andreou, Laura Egloff, Fabienne Harrisberger, Ulrike Heitz, Claudia Lenz, Letizia Leanza, Amatya Mackintosh, Renata Smieskova, Erich Studerus, Anna Walter, Sonja Widmayer. <italic>Institute for Mental Health &amp; School of Psychology, University of Birmingham, United Kingdom:</italic> Chris Day, Sian Lowri Griffiths, Mariam Iqbal, Mirabel Pelton, Pavan Mallikarjun, Alexandra Stainton, Ashleigh Lin, Paris Lalousis. <italic>Department of Psychiatry, University of Turku, Finland</italic><bold>:</bold> Alexander Denissoff, Anu Ellilä, Tiina From, Markus Heinimaa, Tuula Ilonen, Päivi Jalo, Heikki Laurikainen, Antti Luutonen, Akseli Mäkela, Janina Paju, Henri Pesonen, Reetta-Liina Säilä, Anna Toivonen, Otto Turtonen. <italic>Department of Psychiatry (Psychiatric University Hospital LVR/HHU Düsseldorf), University of Düsseldorf, Germany:</italic> Sonja Botterweck, Norman Kluthausen, Gerald Antoch, Julian Caspers, Hans-Jörg Wittsack. <italic>General Electric Global Research Inc., USA</italic>. Ana Beatriz Solana, Manuela Abraham, Timo Schirmer. <italic>Workgroup of Paolo Brambilla, University of Milan, Italy:</italic> Department of Neuroscience and Mental Health, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy: Carlo Altamura, Marika Belleri, Francesca Bottinelli, Adele Ferro, Marta Re. Programma2000, Niguarda Hospital, Milan: Emiliano Monzani, Maurizio Sberna. San Paolo Hospital, Milan: Armando D’Agostino, Lorenzo Del Fabro. Villa San Benedetto Menni, Albese con Cassano (CO): Giampaolo Perna, Maria Nobile, Alessandra Alciati. <italic>Workgroup of Paolo Brambilla at the University of Udine, Italy</italic>. Department of Medical Area, University of Udine, Udine, Italy: Matteo Balestrieri, Carolina Bonivento, Giuseppe Cabras, Franco Fabbro. IRCCS Scientific Institute “E. Medea”, Polo FVG, Udine: Marco Garzitto, Sara Piccin</p>
    </ack>
    <notes notes-type="author-contribution">
      <title>Author contributions</title>
      <p>JMS, IM, MS, and RL designed the study, conducted the analyses, interpreted the data with respect to the specific aspect of visual dysfunctions, and drafted the manuscript. LAA, LK-I, UD, TH, TL, DBD, OB, GR, AR, SSH, and RU made substantial contributions to the analyses and interpretation of the data and revised the manuscript critically. JK, RU, RKRS, CP, EM, SB, PB, AB, and NK conceptualized the PRONIA study, were responsible for data acquisition, and revised the manuscript critically. All authors gave their final approval of the version to be published and agreed to be accountable for all aspects of the work.</p>
    </notes>
    <notes notes-type="funding-information">
      <title>Funding</title>
      <p>The presented work was supported by the grant for the Personalized Prognostic Indicators for early Psychosis management (PRONIA Study): EU-FP7-HEALTH; agreement number: 602152. LK-I is a recipient of an NARSAD Young Investigator Award of the Brain &amp; Behavior Research Foundation No. 28474. TL was additionally supported by the Koeln Fortune Program/Faculty of Medicine, University of Cologne. RL received additional funding from the European Unions Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No. 734227. Open Access funding enabled and organized by Projekt DEAL.</p>
    </notes>
    <notes id="FPar1" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par48">RU reports grants from the Medical Research Council, National Institute for Health Research: Health Technology Assessment, the National Institute of Mental Health, and personal fees from Sunovion, Springer Heathcare and Vitaris outside the submitted work. TL reports funding from Koeln Fortune Program/Faculty of Medicine, University of Cologne (No 370/2020) outside the submitted work. RL participated in advisory boards and received honoraria for talks presented at educational meetings organized by Janssen-Cilag, Otsuka/Lundbeck and ROVI outside the submitted work. No other conflicts of interest were reported.</p>
    </notes>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="other">American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.</mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chapman</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Chapman</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Scales for rating psychotic and psychotic-like experiences as continua</article-title>
          <source>Schizophr Bull</source>
          <year>1980</year>
          <volume>6</volume>
          <fpage>477</fpage>
          <lpage>89.</lpage>
          <pub-id pub-id-type="doi">10.1093/schbul/6.3.476</pub-id>
          <pub-id pub-id-type="pmid">7403809</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Butler</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Silverstein</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Dakin</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>Visual perception and its impairment in schizophrenia</article-title>
          <source>Biol Psychiatry</source>
          <year>2008</year>
          <volume>64</volume>
          <fpage>40</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1016/j.biopsych.2008.03.023</pub-id>
          <pub-id pub-id-type="pmid">18549875</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>King</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Hodgekins</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chouinard</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Chouinard</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Sperandio</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>A review of abnormalities in the perception of visual illusions in schizophrenia</article-title>
          <source>Psychon Bull Rev</source>
          <year>2017</year>
          <volume>24</volume>
          <fpage>734</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="doi">10.3758/s13423-016-1168-5</pub-id>
          <pub-id pub-id-type="pmid">27730532</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="other">Silverstein SM. Visual perception disturbances in schizophrenia: a unified model. Nebraska Symp Motiv. 2016;63:77–132.</mixed-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <mixed-citation publication-type="other">Schultze-Lutter F, Addington J, Ruhrmann S, Klosterkötter J. The schizophrenia proneness instrument, adult version (SPI-A). Giovanni Fioriti Editore: Rome, Italy; 2007.</mixed-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klosterkötter</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ebel</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schultze-Lutter</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Steinmeyer</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>Diagnostic validity of basic symptoms</article-title>
          <source>Eur Arch Psychiatry Clin Neurosci</source>
          <year>1996</year>
          <volume>246</volume>
          <fpage>147</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="doi">10.1007/BF02189116</pub-id>
          <pub-id pub-id-type="pmid">8739400</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schultze-Lutter</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ruhrmann</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Picker</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>von Reventlow</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Brockhaus-Dumke</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Klosterkötter</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Basic symptoms in early psychotic and depressive disorders</article-title>
          <source>Br J Psychiatry</source>
          <year>2007</year>
          <volume>51</volume>
          <fpage>s31</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1192/bjp.191.51.s31</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kiss</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Fábián</surname>
              <given-names>Á</given-names>
            </name>
            <name>
              <surname>Benedek</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kéri</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>When doors of perception open: visual contrast sensitivity in never-medicated, first-episode schizophrenia</article-title>
          <source>J Abnorm Psychol</source>
          <year>2010</year>
          <volume>119</volume>
          <fpage>586</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="doi">10.1037/a0019610</pub-id>
          <pub-id pub-id-type="pmid">20677847</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kelemen</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Kiss</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Benedek</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kéri</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Perceptual and cognitive effects of antipsychotics in first-episode schizophrenia: the potential impact of GABA concentration in the visual cortex</article-title>
          <source>Prog Neuropsychopharmacol Biol Psychiatry</source>
          <year>2013</year>
          <volume>47</volume>
          <fpage>13</fpage>
          <lpage>19</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pnpbp.2013.07.024</pub-id>
          <pub-id pub-id-type="pmid">23954737</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Green</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wynn</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Mathis</surname>
              <given-names>KI</given-names>
            </name>
          </person-group>
          <article-title>Visual masking in schizophrenia: overview and theoretical implications</article-title>
          <source>Schizophr Bull</source>
          <year>2011</year>
          <volume>37</volume>
          <fpage>700</fpage>
          <pub-id pub-id-type="doi">10.1093/schbul/sbr051</pub-id>
          <pub-id pub-id-type="pmid">21606322</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <mixed-citation publication-type="other">Dakin S, Carlin P, Hemsley D. Weak suppression of visual context in chronic schizophrenia. Curr Biol. 2005;15:R822–4.</mixed-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silverstein</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Keane</surname>
              <given-names>BP</given-names>
            </name>
          </person-group>
          <article-title>Perceptual organization impairment in schizophrenia and associated brain mechanisms: review of research from 2005 to 2010</article-title>
          <source>Schizophr Bull</source>
          <year>2011</year>
          <volume>37</volume>
          <fpage>690</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1093/schbul/sbr052</pub-id>
          <pub-id pub-id-type="pmid">21700589</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Montalvo</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Clinicoradiological correlation of macropsia due to acute stroke: a case report and review of the literature</article-title>
          <source>Case Rep Neurol Med</source>
          <year>2014</year>
          <volume>2014</volume>
          <fpage>1</fpage>
          <lpage>3</lpage>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nestmann</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Karnath</surname>
              <given-names>H-O</given-names>
            </name>
            <name>
              <surname>Rennig</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Hemifield-specific color perception deficits after unilateral V4α lesions</article-title>
          <source>Cortex.</source>
          <year>2021</year>
          <volume>142</volume>
          <fpage>357</fpage>
          <lpage>69</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cortex.2021.06.009</pub-id>
          <pub-id pub-id-type="pmid">34358731</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schultze-Lutter</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Debbané</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Theodoridou</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Raballo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Michel</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Revisiting the basic symptom concept: toward translating risk symptoms for psychosis into neurobiological targets</article-title>
          <source>Front Psychiatry</source>
          <year>2016</year>
          <volume>7</volume>
          <fpage>1</fpage>
          <lpage>15.</lpage>
          <pub-id pub-id-type="doi">10.3389/fpsyt.2016.00009</pub-id>
          <pub-id pub-id-type="pmid">26903886</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klosterkötter</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hellmich</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Steinmeyer</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Schultze-Lutter</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Diagnosing schizophrenia in the initial prodromal phase</article-title>
          <source>Arch Gen Psychiatry</source>
          <year>2001</year>
          <volume>58</volume>
          <fpage>158</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="doi">10.1001/archpsyc.58.2.158</pub-id>
          <pub-id pub-id-type="pmid">11177117</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schultze-Lutter</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Klosterkötter</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Picker</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Steinmeyer</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Ruhrmann</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Predicting first-episode psychosis by basic symptom criteria</article-title>
          <source>Clin Neuropsychiatry</source>
          <year>2007</year>
          <volume>4</volume>
          <fpage>11</fpage>
          <lpage>22</lpage>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schultze-Lutter</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ruhrmann</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fusar-Poli</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bechdolf</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schimmelmann</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Klosterkötter</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Basic symptoms and the prediction of first-episode psychosis</article-title>
          <source>Curr Pharm Des</source>
          <year>2012</year>
          <volume>18</volume>
          <fpage>351</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.2174/138161212799316064</pub-id>
          <pub-id pub-id-type="pmid">22239566</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schultze-Lutter</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ruhrmann</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Michel</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kindler</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Schimmelmann</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>Age effects on basic symptoms in the community: a route to gain new insight into the neurodevelopment of psychosis?</article-title>
          <source>Eur Arch Psychiatry Clin Neurosci</source>
          <year>2020</year>
          <volume>270</volume>
          <fpage>311</fpage>
          <pub-id pub-id-type="doi">10.1007/s00406-018-0949-4</pub-id>
          <pub-id pub-id-type="pmid">30361925</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walger</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Antonucci</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Pigoni</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Upthegrove</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Salokangas</surname>
              <given-names>RKR</given-names>
            </name>
            <name>
              <surname>Lencer</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Basic symptoms are associated with age in patients with a clinical high-risk state for psychosis: results from the PRONIA study</article-title>
          <source>Front Psychiatry</source>
          <year>2020</year>
          <volume>11</volume>
          <fpage>1268</fpage>
          <pub-id pub-id-type="doi">10.3389/fpsyt.2020.552175</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dosenbach</surname>
              <given-names>NUF</given-names>
            </name>
            <name>
              <surname>Nardos</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Fair</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Power</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Church</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prediction of individual brain maturity using fMRI</article-title>
          <source>Science</source>
          <year>2010</year>
          <volume>329</volume>
          <fpage>1358</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1194144</pub-id>
          <pub-id pub-id-type="pmid">20829489</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kastner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pinsk</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Visual attention as a multilevel selection process</article-title>
          <source>Cogn Affect Behav Neurosci</source>
          <year>2004</year>
          <volume>4</volume>
          <fpage>483</fpage>
          <lpage>500</lpage>
          <pub-id pub-id-type="doi">10.3758/CABN.4.4.483</pub-id>
          <pub-id pub-id-type="pmid">15849892</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scolari</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Seidl-Rathkopf</surname>
              <given-names>KN</given-names>
            </name>
            <name>
              <surname>Kastner</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Functions of the human frontoparietal attention network: evidence from neuroimaging</article-title>
          <source>Curr Opin Behav Sci</source>
          <year>2015</year>
          <volume>1</volume>
          <fpage>32</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cobeha.2014.08.003</pub-id>
          <pub-id pub-id-type="pmid">27398396</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Flint</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Cearns</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Opel</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Redlich</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mehler</surname>
              <given-names>DMA</given-names>
            </name>
            <name>
              <surname>Emden</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Systematic misestimation of machine learning performance in neuroimaging studies of depression</article-title>
          <source>Neuropsychopharmacology.</source>
          <year>2021</year>
          <volume>46</volume>
          <fpage>1510</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1038/s41386-021-01020-7</pub-id>
          <pub-id pub-id-type="pmid">33958703</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hahn</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nierenberg</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Whitfield-Gabrieli</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Predictive analytics in mental health: applications, guidelines, challenges and perspectives</article-title>
          <source>Mol Psychiatry</source>
          <year>2017</year>
          <volume>22</volume>
          <fpage>37</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="doi">10.1038/mp.2016.201</pub-id>
          <pub-id pub-id-type="pmid">27843153</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koutsouleris</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kambeitz-Ilankovic</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ruhrmann</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rosen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ruef</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dwyer</surname>
              <given-names>DB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prediction models of functional outcomes for individuals in the clinical high-risk state for psychosis or with recent-onset depression: a multimodal, multisite machine learning analysis</article-title>
          <source>JAMA Psychiatry</source>
          <year>2018</year>
          <volume>75</volume>
          <fpage>1156</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2018.2165</pub-id>
          <pub-id pub-id-type="pmid">30267047</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <mixed-citation publication-type="other">German Association for Psychiatry, Psychotherapy and Psychosomatics, DGPPN (Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde e. V.). S3 guideline for schizophrenia. 2019.</mixed-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lencer</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Meyhöfer</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Triebsch</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rolfes</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lappe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Watson</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Saccadic suppression in schizophrenia</article-title>
          <source>Sci Rep</source>
          <year>2021</year>
          <volume>11</volume>
          <fpage>1</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="doi">10.1038/s41598-021-92531-2</pub-id>
          <pub-id pub-id-type="pmid">33414495</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beck</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Steer</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Ball</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ranieri</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Comparison of Beck depression inventories-Ia and II in psychiatric outpatients</article-title>
          <source>J Pers Assess</source>
          <year>1996</year>
          <volume>67</volume>
          <fpage>588</fpage>
          <lpage>97</lpage>
          <pub-id pub-id-type="doi">10.1207/s15327752jpa6703_13</pub-id>
          <pub-id pub-id-type="pmid">8991972</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kay</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Fiszbein</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Opler</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>The positive and negative syndrome scale (PANSS) for schizophrenia</article-title>
          <source>Schizophr Bull</source>
          <year>1987</year>
          <volume>13</volume>
          <fpage>261</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="doi">10.1093/schbul/13.2.261</pub-id>
          <pub-id pub-id-type="pmid">3616518</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Llorca</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Lançon</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lancrenon</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bayle</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Caci</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Rouillon</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The ‘Functional Remission of General Schizophrenia’ (FROGS) scale: development and validation of a new questionnaire</article-title>
          <source>Schizophr Res</source>
          <year>2009</year>
          <volume>113</volume>
          <fpage>218</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="doi">10.1016/j.schres.2009.04.029</pub-id>
          <pub-id pub-id-type="pmid">19464855</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <mixed-citation publication-type="other">Niendam TA, Bearden CE, Johnson JK, Cannon TD. Global Functioning: Role Scale (GF: Role). Los Angeles, CA: University of California, Los Angeles; 2006.</mixed-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <mixed-citation publication-type="other">Auther, AM, Smith, CW, Cornblatt BA. Global Functioning: Social Scale (GF: Social). Glen Oaks, NY: Zucker Hillside Hospital; 2006.</mixed-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Power</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kuyken</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties</article-title>
          <source>Soc Sci Med</source>
          <year>1998</year>
          <volume>46</volume>
          <fpage>1569</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="doi">10.1016/S0277-9536(98)00009-4</pub-id>
          <pub-id pub-id-type="pmid">9672396</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <mixed-citation publication-type="other">Rey A. L’examen psychologique dans les cas d’encephopathie traumatique. Arch Psychol. 1941;28:286–340.</mixed-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Osterrieth</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>Le test de copie d’une figure complexe</article-title>
          <source>Arch Psychol</source>
          <year>1944</year>
          <volume>30</volume>
          <fpage>286</fpage>
          <lpage>356</lpage>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mervis</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Pani</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Visuospatial construction</article-title>
          <source>Am J Hum Genet</source>
          <year>1999</year>
          <volume>65</volume>
          <fpage>1222</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1086/302633</pub-id>
          <pub-id pub-id-type="pmid">10521286</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Holm</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>A simple sequentially rejective multiple test procedure</article-title>
          <source>Scand J Stat</source>
          <year>1979</year>
          <volume>6</volume>
          <fpage>65</fpage>
          <lpage>70</lpage>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <mixed-citation publication-type="other">Haas SS, Antonucci LA, Wenzel J, Ruef A, Biagianti B, Paolini M, et al. A multivariate neuromonitoring approach to neuroplasticity-based computerized cognitive training in recent onset psychosis. Neuropsychopharmacology. 2020;46:1–8.</mixed-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Orban</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Desseilles</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mendrek</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bourque</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bellec</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Stip</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Altered brain connectivity in patients with schizophrenia is consistent across cognitive contexts</article-title>
          <source>J Psychiatry Neurosci</source>
          <year>2017</year>
          <volume>42</volume>
          <fpage>17</fpage>
          <lpage>26</lpage>
          <pub-id pub-id-type="doi">10.1503/jpn.150247</pub-id>
          <pub-id pub-id-type="pmid">27091719</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kapur</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Insel</surname>
              <given-names>TR</given-names>
            </name>
          </person-group>
          <article-title>Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it</article-title>
          <source>Mol Psychiatry</source>
          <year>2012</year>
          <volume>17</volume>
          <fpage>1174</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1038/mp.2012.105</pub-id>
          <pub-id pub-id-type="pmid">22869033</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wei</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Womer</surname>
              <given-names>FY</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Local functional connectivity alterations in schizophrenia, bipolar disorder, and major depressive disorder</article-title>
          <source>J Affect Disord</source>
          <year>2018</year>
          <volume>236</volume>
          <fpage>266</fpage>
          <lpage>73</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jad.2018.04.069</pub-id>
          <pub-id pub-id-type="pmid">29751242</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Zeng</surname>
              <given-names>L-L</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Qin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Functional network connectivity alterations in schizophrenia and depression</article-title>
          <source>Psychiatry Res Neuroimaging</source>
          <year>2017</year>
          <volume>263</volume>
          <fpage>113</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pscychresns.2017.03.012</pub-id>
          <pub-id pub-id-type="pmid">28371656</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harris</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Perceptual changes in schizophrenia: a questionnaire survey</article-title>
          <source>Psychol Med</source>
          <year>1985</year>
          <volume>15</volume>
          <fpage>859</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="doi">10.1017/S0033291700005092</pub-id>
          <pub-id pub-id-type="pmid">4080889</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cutting</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dunne</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>The nature of the abnormal perceptual experiences at the onset of schizophrenia</article-title>
          <source>Psychopathology.</source>
          <year>1986</year>
          <volume>19</volume>
          <fpage>347</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="doi">10.1159/000284459</pub-id>
          <pub-id pub-id-type="pmid">3615790</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koethe</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kranaster</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hoyer</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gross</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Neatby</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Schultze-Lutter</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Binocular depth inversion as a paradigm of reduced visual information processing in prodromal state, antipsychotic-naïve and treated schizophrenia</article-title>
          <source>Eur Arch Psychiatry Clin Neurosci</source>
          <year>2009</year>
          <volume>259</volume>
          <fpage>195</fpage>
          <lpage>202</lpage>
          <pub-id pub-id-type="doi">10.1007/s00406-008-0851-6</pub-id>
          <pub-id pub-id-type="pmid">19165523</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schubert</surname>
              <given-names>EW</given-names>
            </name>
            <name>
              <surname>Henriksson</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>McNeil</surname>
              <given-names>TF</given-names>
            </name>
          </person-group>
          <article-title>A prospective study of offspring of women with psychosis: visual dysfunction in early childhood predicts schizophrenia-spectrum disorders in adulthood</article-title>
          <source>Acta Psychiatr Scand</source>
          <year>2005</year>
          <volume>112</volume>
          <fpage>385</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1600-0447.2005.00584.x</pub-id>
          <pub-id pub-id-type="pmid">16223427</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Waters</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Collerton</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ffytche</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Jardri</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pins</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dudley</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Visual hallucinations in the psychosis spectrum and comparative information from neurodegenerative disorders and eye disease</article-title>
          <source>Schizophr Bull</source>
          <year>2014</year>
          <volume>40</volume>
          <fpage>233</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="doi">10.1093/schbul/sbu036</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uhlhaas</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Silverstein</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Perceptual organization in schizophrenia spectrum disorders: empirical research and theoretical implications</article-title>
          <source>Psychol Bull</source>
          <year>2005</year>
          <volume>131</volume>
          <fpage>618</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="doi">10.1037/0033-2909.131.4.618</pub-id>
          <pub-id pub-id-type="pmid">16060805</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hébert</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gagné</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Paradis</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Jomphe</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Roy</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Mérette</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Retinal response to light in young nonaffected offspring at high genetic risk of neuropsychiatric brain disorders</article-title>
          <source>Biol Psychiatry</source>
          <year>2010</year>
          <volume>67</volume>
          <fpage>270</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1016/j.biopsych.2009.08.016</pub-id>
          <pub-id pub-id-type="pmid">19833322</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mittal</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Keane</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Silverstein</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Visual context processing dysfunctions in youth at high risk for psychosis: resistance to the ebbinghaus illusion and its symptom and social and role functioning correlates</article-title>
          <source>J Abnorm Psychol</source>
          <year>2015</year>
          <volume>124</volume>
          <fpage>953</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="doi">10.1037/abn0000082</pub-id>
          <pub-id pub-id-type="pmid">26237183</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silverstein</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Harms</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Carter</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Gold</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Keane</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>MacDonald</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cortical contributions to impaired contour integration in schizophrenia</article-title>
          <source>Neuropsychologia.</source>
          <year>2015</year>
          <volume>75</volume>
          <fpage>469</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuropsychologia.2015.07.003</pub-id>
          <pub-id pub-id-type="pmid">26160288</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Revheim</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Corcoran</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Dias</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hellmann</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Martinez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Butler</surname>
              <given-names>PD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Reading deficits in schizophrenia and individuals at high clinical risk: relationship to sensory function, course of illness, and psychosocial outcome</article-title>
          <source>Am J Psychiatry</source>
          <year>2014</year>
          <volume>171</volume>
          <fpage>949</fpage>
          <lpage>59</lpage>
          <pub-id pub-id-type="doi">10.1176/appi.ajp.2014.13091196</pub-id>
          <pub-id pub-id-type="pmid">25178752</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Granö</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Salmijärvi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Karjalainen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kallionpää</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Roine</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Early signs of worry: psychosis risk symptom visual distortions are independently associated with suicidal ideation</article-title>
          <source>Psychiatry Res</source>
          <year>2015</year>
          <volume>225</volume>
          <fpage>263</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1016/j.psychres.2014.12.031</pub-id>
          <pub-id pub-id-type="pmid">25595340</pub-id>
        </element-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hui</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Morcillo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Russo</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Stochl</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Shelley</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Painter</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Psychiatric morbidity, functioning and quality of life in young people at clinical high risk for psychosis</article-title>
          <source>Schizophr Res</source>
          <year>2013</year>
          <volume>148</volume>
          <fpage>175</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="doi">10.1016/j.schres.2013.05.026</pub-id>
          <pub-id pub-id-type="pmid">23773297</pub-id>
        </element-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Calderone</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Hoptman</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Martínez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nair-Collins</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mauro</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Bar</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Contributions of low and high spatial frequency processing to impaired object recognition circuitry in schizophrenia</article-title>
          <source>Cereb Cortex</source>
          <year>2012</year>
          <volume>23</volume>
          <fpage>1849</fpage>
          <lpage>58</lpage>
          <pub-id pub-id-type="doi">10.1093/cercor/bhs169</pub-id>
          <pub-id pub-id-type="pmid">22735157</pub-id>
        </element-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haenschel</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bittner</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Haertling</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rotarska-Jagiela</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Maurer</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Singer</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Contribution of impaired early-stage visual processing to working memory dysfunction in adolescents with schizophrenia: a study with event-related potentials and functional magnetic resonance imaging</article-title>
          <source>Arch Gen Psychiatry</source>
          <year>2007</year>
          <volume>64</volume>
          <fpage>1229</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="doi">10.1001/archpsyc.64.11.1229</pub-id>
          <pub-id pub-id-type="pmid">17984392</pub-id>
        </element-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hebart</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Hesselmann</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>What visual information is processed in the human dorsal stream?</article-title>
          <source>J Neurosci</source>
          <year>2012</year>
          <volume>32</volume>
          <fpage>8107</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1462-12.2012</pub-id>
          <pub-id pub-id-type="pmid">22699890</pub-id>
        </element-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silverstein</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The phenomenology and neurobiology of visual distortions and hallucinations in schizophrenia: an update</article-title>
          <source>Front Psychiatry</source>
          <year>2021</year>
          <volume>12</volume>
          <fpage>1</fpage>
          <lpage>18.</lpage>
          <pub-id pub-id-type="doi">10.3389/fpsyt.2021.684720</pub-id>
        </element-citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silverstein</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Demmin</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Schallek</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Fradkin</surname>
              <given-names>SI</given-names>
            </name>
          </person-group>
          <article-title>Measures of retinal structure and function as biomarkers in neurology and psychiatry</article-title>
          <source>Biomark Neuropsychiatry</source>
          <year>2020</year>
          <volume>2</volume>
          <fpage>100018</fpage>
          <pub-id pub-id-type="doi">10.1016/j.bionps.2020.100018</pub-id>
        </element-citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wylie</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pasternak</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Butler</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Javitt</surname>
              <given-names>DC</given-names>
            </name>
          </person-group>
          <article-title>Magnocellular contributions to impaired motion processing in schizophrenia</article-title>
          <source>Schizophr Res</source>
          <year>2006</year>
          <volume>82</volume>
          <fpage>1</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1016/j.schres.2005.10.008</pub-id>
          <pub-id pub-id-type="pmid">16325377</pub-id>
        </element-citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kéri</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kiss</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kelemen</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Benedek</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Janka</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Anomalous visual experiences, negative symptoms, perceptual organization and the magnocellular pathway in schizophrenia: a shared construct?</article-title>
          <source>Psychol Med</source>
          <year>2005</year>
          <volume>35</volume>
          <fpage>1445</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="doi">10.1017/S0033291705005398</pub-id>
          <pub-id pub-id-type="pmid">16164768</pub-id>
        </element-citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silverstein</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Rosen</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Schizophrenia and the eye</article-title>
          <source>Schizophr Res Cogn</source>
          <year>2015</year>
          <volume>2</volume>
          <fpage>46</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="doi">10.1016/j.scog.2015.03.004</pub-id>
          <pub-id pub-id-type="pmid">26345525</pub-id>
        </element-citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andreou</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Borgwardt</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Structural and functional imaging markers for susceptibility to psychosis</article-title>
          <source>Mol Psychiatry</source>
          <year>2020</year>
          <volume>25</volume>
          <fpage>2773</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="doi">10.1038/s41380-020-0679-7</pub-id>
          <pub-id pub-id-type="pmid">32066828</pub-id>
        </element-citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hahamy</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wilf</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rosin</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Behrmann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Malach</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>How do the blind ‘see’? The role of spontaneous brain activity in self-generated perception</article-title>
          <source>Brain.</source>
          <year>2021</year>
          <volume>144</volume>
          <fpage>340</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="doi">10.1093/brain/awaa384</pub-id>
          <pub-id pub-id-type="pmid">33367630</pub-id>
        </element-citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <mixed-citation publication-type="other">Mastria G, Mancini V, Viganò A, Di Piero V. Alice in wonderland syndrome: a clinical and pathophysiological review. Biomed Res Int. 2016;2016:8243145.</mixed-citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dima</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Roiser</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Dietrich</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Bonnemann</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lanfermann</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Emrich</surname>
              <given-names>HM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Understanding why patients with schizophrenia do not perceive the hollow-mask illusion using dynamic causal modelling</article-title>
          <source>Neuroimage.</source>
          <year>2009</year>
          <volume>46</volume>
          <fpage>1180</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuroimage.2009.03.033</pub-id>
          <pub-id pub-id-type="pmid">19327402</pub-id>
        </element-citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dima</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dietrich</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Dillo</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Emrich</surname>
              <given-names>HM</given-names>
            </name>
          </person-group>
          <article-title>Impaired top-down processes in schizophrenia: a DCM study of ERPs</article-title>
          <source>Neuroimage.</source>
          <year>2010</year>
          <volume>52</volume>
          <fpage>824</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuroimage.2009.12.086</pub-id>
          <pub-id pub-id-type="pmid">20056155</pub-id>
        </element-citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gupta</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Silverstein</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Bernard</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Keane</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Papathomas</surname>
              <given-names>TV</given-names>
            </name>
            <name>
              <surname>Pelletier-Baldelli</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Disruptions in neural connectivity associated with reduced susceptibility to a depth inversion illusion in youth at ultra high risk for psychosis</article-title>
          <source>NeuroImage Clin</source>
          <year>2016</year>
          <volume>12</volume>
          <fpage>681</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="doi">10.1016/j.nicl.2016.09.022</pub-id>
          <pub-id pub-id-type="pmid">27761399</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
